Completed PHASE2 INTERVENTIONAL 2-arm NCT03427229

Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection

Randomized Clinical Trial: Single Versus Multiple-infusion Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection

Sponsor: Catholic University of the Sacred Heart

Conditions Clostridium Difficile Pseudomembranous Colitis

Interventions Single-infusion FMT Vancomycin (before randomization) multiple-infusion FMT

Updated 5 times since 2018 Last updated: Feb 2, 2018 Started: Mar 31, 2016 Primary completion: Oct 30, 2017 Completion: Oct 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03427229, this PHASE2 trial focuses on Clostridium Difficile and Pseudomembranous Colitis and remains completed. Sponsored by Catholic University of the Sacred Heart, it has been updated 5 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Mar 2018 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catholic University of the Sacred Heart

Data source: Catholic University of the Sacred Heart

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.